• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖皮质激素受体通过与近端启动子区域的糖皮质激素反应元件结合来调节转录。

Glucocorticoid Receptor Regulates Transcription by Binding to Glucocorticoid Responsive Element in Proximal Promoter Region.

机构信息

The Chair of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia.

出版信息

Int J Mol Sci. 2021 Jan 21;22(3):1054. doi: 10.3390/ijms22031054.

DOI:10.3390/ijms22031054
PMID:33494362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7865994/
Abstract

Glucocorticoid osteoporosis is a serious side effect of long term glucocorticoid uptake and it is caused by osteoblast apoptosis and imbalance in the major bone remodeling pathway RANK/RANKL/OPG. The impact of glucocorticoid on the maintenance of RANK/RANKL/OPG is well explored; dexamethasone was shown to disturb the ratio between and level by decreasing the expression level of and increasing level of . Here, were aimed to decipher whether glucocorticoid receptor directly influences promoter activity and its transcriptional regulation. We demonstrate that overexpression of glucocorticoid receptor (GR) NR3C1 increased promoter activity in human osteosarcoma, cervical cancer (2-fold) and adenocarcinoma cells (4.5-fold). Mutational analysis revealed that +352 site in the promoter is functional glucocorticoid responsive element (GRE) since the effect of GR on promoter activity was diminished by mutation at this site. Overexpression of upregulated mRNA expression 1.5-fold in human A549 and HOS cells. On the other hand silencing of caused slight decrease in mRNA level, suggesting that NR3C1 directly accounts for transcriptional regulation. Using electrophoretic mobility shift assay we demonstrate that NR3C1 binds to the proximal promoter region. Our study provides evidences that NR3C1 directly upregulates transcription in human cell lines and connects the missing link in the mechanism of RANK/RANKL/OPG imbalance of glucocorticoid induced osteoporosis.

摘要

糖皮质激素性骨质疏松症是长期糖皮质激素摄入的严重副作用,它是由成骨细胞凋亡和主要骨重塑途径 RANK/RANKL/OPG 失衡引起的。糖皮质激素对 RANK/RANKL/OPG 维持的影响已经得到了充分的研究;地塞米松通过降低 和增加 的表达水平,显示出干扰 和 水平之间的比例,从而扰乱了两者之间的平衡。在这里,我们旨在破译糖皮质激素受体是否直接影响 启动子活性及其转录调控。我们证明,糖皮质激素受体(GR)NR3C1 的过表达增加了人骨肉瘤、宫颈癌(2 倍)和腺癌细胞(4.5 倍)中的 启动子活性。突变分析表明, 启动子中的+352 位点是功能性糖皮质激素反应元件(GRE),因为该位点的突变减弱了 GR 对 启动子活性的影响。过表达 在人 A549 和 HOS 细胞中上调 mRNA 表达 1.5 倍。另一方面,沉默 导致 mRNA 水平略有下降,表明 NR3C1 直接负责 转录调控。通过电泳迁移率变动分析,我们证明 NR3C1 与 启动子的近端区域结合。我们的研究提供了证据,表明 NR3C1 直接上调人细胞系中的 转录,并连接了糖皮质激素诱导骨质疏松症中 RANK/RANKL/OPG 失衡机制中的缺失环节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da50/7865994/f698ed5f1d40/ijms-22-01054-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da50/7865994/51b553197178/ijms-22-01054-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da50/7865994/e1afacb9bfb6/ijms-22-01054-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da50/7865994/3e71dc19b4d3/ijms-22-01054-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da50/7865994/3a506c08f01e/ijms-22-01054-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da50/7865994/6e6252f27432/ijms-22-01054-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da50/7865994/f698ed5f1d40/ijms-22-01054-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da50/7865994/51b553197178/ijms-22-01054-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da50/7865994/e1afacb9bfb6/ijms-22-01054-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da50/7865994/3e71dc19b4d3/ijms-22-01054-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da50/7865994/3a506c08f01e/ijms-22-01054-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da50/7865994/6e6252f27432/ijms-22-01054-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da50/7865994/f698ed5f1d40/ijms-22-01054-g006.jpg

相似文献

1
Glucocorticoid Receptor Regulates Transcription by Binding to Glucocorticoid Responsive Element in Proximal Promoter Region.糖皮质激素受体通过与近端启动子区域的糖皮质激素反应元件结合来调节转录。
Int J Mol Sci. 2021 Jan 21;22(3):1054. doi: 10.3390/ijms22031054.
2
Glucocorticoid resistance in a multiple myeloma cell line is regulated by a transcription elongation block in the glucocorticoid receptor gene (NR3C1).多发性骨髓瘤细胞系中的糖皮质激素抵抗由糖皮质激素受体基因(NR3C1)中的转录延伸阻滞所调控。
Br J Haematol. 2009 Mar;144(6):856-64. doi: 10.1111/j.1365-2141.2008.07549.x. Epub 2008 Dec 26.
3
Identification of a mineralocorticoid/glucocorticoid response element in the human Na/K ATPase alpha1 gene promoter.人钠钾ATP酶α1基因启动子中盐皮质激素/糖皮质激素反应元件的鉴定
Biochem Biophys Res Commun. 1999 Dec 9;266(1):5-14. doi: 10.1006/bbrc.1999.1765.
4
Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones.糖皮质激素对小鼠颅骨中破骨细胞分化以及核因子-κB受体激活剂(NF-κB)配体、骨保护素和NF-κB受体激活剂表达的调节作用
Endocrinology. 2006 Jul;147(7):3613-22. doi: 10.1210/en.2005-0717. Epub 2006 Apr 13.
5
Response Element Composition Governs Correlations between Binding Site Affinity and Transcription in Glucocorticoid Receptor Feed-forward Loops.应答元件组成决定糖皮质激素受体前馈环中结合位点亲和力与转录之间的相关性。
J Biol Chem. 2015 Aug 7;290(32):19756-69. doi: 10.1074/jbc.M115.668558. Epub 2015 Jun 18.
6
DNA methylation of the glucocorticoid receptor gene promoter in the placenta is associated with blood pressure regulation in human pregnancy.胎盘中糖皮质激素受体基因启动子的DNA甲基化与人类妊娠期间的血压调节有关。
J Hypertens. 2017 Nov;35(11):2276-2286. doi: 10.1097/HJH.0000000000001450.
7
Methylation at the CpG island shore region upregulates Nr3c1 promoter activity after early-life stress.早期生活应激后,CpG岛岸区的甲基化上调Nr3c1启动子活性。
Epigenetics. 2015;10(3):247-57. doi: 10.1080/15592294.2015.1017199.
8
Dexamethasone-mediated up-regulation of human CYP2A6 involves the glucocorticoid receptor and increased binding of hepatic nuclear factor 4 alpha to the proximal promoter.地塞米松介导的人CYP2A6上调涉及糖皮质激素受体以及肝细胞核因子4α与近端启动子结合增加。
Mol Pharmacol. 2008 Feb;73(2):451-60. doi: 10.1124/mol.107.039354. Epub 2007 Oct 31.
9
Tissue expression and promoter activity analysis of the porcine TNFSF11 gene.组织表达和启动子活性分析猪 TNFRSF11 基因。
Theriogenology. 2024 Sep 15;226:277-285. doi: 10.1016/j.theriogenology.2024.06.018. Epub 2024 Jun 26.
10
Identification of multiple glucocorticoid receptor binding sites in the rat osteocalcin gene promoter.大鼠骨钙素基因启动子中多个糖皮质激素受体结合位点的鉴定。
Biochemistry. 1993 Oct 26;32(42):11436-44. doi: 10.1021/bi00093a022.

引用本文的文献

1
Exploring the Interaction Between Sjögren's Syndrome and Osteoporosis: Pathophysiological Mechanisms and Management Strategies.探索干燥综合征与骨质疏松症之间的相互作用:病理生理机制与管理策略。
Int J Gen Med. 2025 Sep 4;18:5137-5153. doi: 10.2147/IJGM.S543209. eCollection 2025.
2
Zuogui Pill Ameliorates Glucocorticoid-Induced Osteoporosis through ZNF702P-Based ceRNA Network: Bioinformatics Analysis and Experimental Validation.左归丸通过基于ZNF702P的ceRNA网络改善糖皮质激素诱导的骨质疏松症:生物信息学分析与实验验证
Evid Based Complement Alternat Med. 2022 Aug 29;2022:8020182. doi: 10.1155/2022/8020182. eCollection 2022.
3

本文引用的文献

1
Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment.糖皮质激素性骨质疏松症的发病机制与治疗选择。
Nat Rev Endocrinol. 2020 Aug;16(8):437-447. doi: 10.1038/s41574-020-0341-0. Epub 2020 Apr 14.
2
Treatment options for glucocorticoid-induced osteoporosis.糖皮质激素性骨质疏松症的治疗选择。
Expert Opin Pharmacother. 2020 Apr;21(6):721-732. doi: 10.1080/14656566.2020.1721467. Epub 2020 Jan 31.
3
A Jack of All Trades: Impact of Glucocorticoids on Cellular Cross-Talk in Osteoimmunology.多面手:糖皮质激素对骨免疫学中细胞串扰的影响。
Changes in RANKL, OPG, and 25(OH)D Levels in Children with Leukemia from Diagnosis to Remission.
白血病患儿从诊断到缓解期RANKL、OPG和25(OH)D水平的变化
Cancers (Basel). 2024 Aug 10;16(16):2811. doi: 10.3390/cancers16162811.
4
Midkine promotes breast cancer cell proliferation and migration by upregulating NR3C1 expression and activating the NF-κB pathway.中期因子通过上调 NR3C1 表达和激活 NF-κB 通路促进乳腺癌细胞增殖和迁移。
Mol Biol Rep. 2022 Apr;49(4):2953-2961. doi: 10.1007/s11033-022-07116-7. Epub 2022 Jan 13.
Front Immunol. 2019 Oct 17;10:2460. doi: 10.3389/fimmu.2019.02460. eCollection 2019.
4
Glucocorticoids employ the monomeric glucocorticoid receptor to potentiate vitamin D and parathyroid hormone-induced osteoclastogenesis.糖皮质激素利用单体糖皮质激素受体增强维生素 D 和甲状旁腺激素诱导的破骨细胞生成。
FASEB J. 2019 Dec;33(12):14394-14409. doi: 10.1096/fj.201802729RRR. Epub 2019 Nov 14.
5
Sex-determining region Y (SRY) attributes to gender differences in RANKL expression and incidence of osteoporosis.性别决定区 Y (SRY) 导致 RANKL 表达和骨质疏松症发病率的性别差异。
Exp Mol Med. 2019 Aug 14;51(8):1-16. doi: 10.1038/s12276-019-0294-3.
6
Glucocorticoid-induced osteoporosis update.糖皮质激素性骨质疏松症更新。
Curr Opin Rheumatol. 2019 Jul;31(4):388-393. doi: 10.1097/BOR.0000000000000608.
7
GLUCOCORTICOID EXCESS IN BONE AND MUSCLE.骨骼和肌肉中的糖皮质激素过量
Clin Rev Bone Miner Metab. 2018 Mar;16(1):33-47. doi: 10.1007/s12018-018-9242-3. Epub 2018 Feb 5.
8
Genetic effects on bone health.遗传对骨骼健康的影响。
Curr Opin Clin Nutr Metab Care. 2018 Jul;21(4):233-239. doi: 10.1097/MCO.0000000000000482.
9
Glucocorticoid-induced osteoporosis: an update.糖皮质激素性骨质疏松症:更新。
Endocrine. 2018 Jul;61(1):7-16. doi: 10.1007/s12020-018-1588-2. Epub 2018 Apr 24.
10
Molecular mechanisms of glucocorticoids on skeleton and bone regeneration after fracture.糖皮质激素对骨骼的分子机制及骨折后骨再生。
J Mol Endocrinol. 2018 Jul;61(1):R75-R90. doi: 10.1530/JME-18-0024. Epub 2018 Mar 27.